Your browser doesn't support javascript.
loading
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms.
Lambourne, Luke; Mattioli, Kaia; Santoso, Clarissa; Sheynkman, Gloria; Inukai, Sachi; Kaundal, Babita; Berenson, Anna; Spirohn-Fitzgerald, Kerstin; Bhattacharjee, Anukana; Rothman, Elisabeth; Shrestha, Shaleen; Laval, Florent; Yang, Zhipeng; Bisht, Deepa; Sewell, Jared A; Li, Guangyuan; Prasad, Anisa; Phanor, Sabrina; Lane, Ryan; Campbell, Devlin M; Hunt, Toby; Balcha, Dawit; Gebbia, Marinella; Twizere, Jean-Claude; Hao, Tong; Frankish, Adam; Riback, Josh A; Salomonis, Nathan; Calderwood, Michael A; Hill, David E; Sahni, Nidhi; Vidal, Marc; Bulyk, Martha L; Fuxman Bass, Juan I.
Afiliación
  • Lambourne L; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mattioli K; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Santoso C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sheynkman G; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Inukai S; Department of Biology, Boston University, Boston, MA, USA.
  • Kaundal B; Bioinformatics Program, Boston University, Boston, MA, USA.
  • Berenson A; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Spirohn-Fitzgerald K; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Bhattacharjee A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rothman E; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Shrestha S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Laval F; Molecular Biology, Cell Biology & Biochemistry Program, Boston University, Boston, MA, USA.
  • Yang Z; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bisht D; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Sewell JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li G; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Prasad A; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Phanor S; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Lane R; Department of Biology, Boston University, Boston, MA, USA.
  • Campbell DM; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hunt T; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Balcha D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gebbia M; TERRA Teaching and Research Centre, University of Liège, Gembloux, Belgium.
  • Twizere JC; Laboratory of Viral Interactomes, GIGA Institute, University of Liège, Liège, Belgium.
  • Hao T; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Frankish A; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Riback JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Salomonis N; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Calderwood MA; Department of Biology, Boston University, Boston, MA, USA.
  • Hill DE; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Sahni N; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Vidal M; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Bulyk ML; Harvard College, Cambridge MA, USA.
  • Fuxman Bass JI; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
bioRxiv ; 2024 Apr 10.
Article en En | MEDLINE | ID: mdl-38617209
ABSTRACT
Most human Transcription factors (TFs) genes encode multiple protein isoforms differing in DNA binding domains, effector domains, or other protein regions. The global extent to which this results in functional differences between isoforms remains unknown. Here, we systematically compared 693 isoforms of 246 TF genes, assessing DNA binding, protein binding, transcriptional activation, subcellular localization, and condensate formation. Relative to reference isoforms, two-thirds of alternative TF isoforms exhibit differences in one or more molecular activities, which often could not be predicted from sequence. We observed two primary categories of alternative TF isoforms "rewirers" and "negative regulators", both of which were associated with differentiation and cancer. Our results support a model wherein the relative expression levels of, and interactions involving, TF isoforms add an understudied layer of complexity to gene regulatory networks, demonstrating the importance of isoform-aware characterization of TF functions and providing a rich resource for further studies.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos